Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination treatments for schizophrenia.

Alexander L Miller1

  • 1Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA. millera@uthscsa.edu

CNS Spectrums
|September 14, 2004
PubMed
Summary

Combination antipsychotic treatments for schizophrenia lack strong evidence. Clozapine augmentation shows promise for positive symptoms, but data for cognitive and negative symptoms remain insufficient.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The COMPASS scale for the assessment of individuals with first episode psychotic disorders.

Schizophrenia research·2024
Same author

Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial.

Schizophrenia bulletin·2022
Same author

Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention.

The American journal of psychiatry·2017
Same author

Hospitalization Risk Before and After Employment Among Adults With Schizophrenia, Bipolar Disorder, or Major Depression.

Psychiatric services (Washington, D.C.)·2016
Same author

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

The American journal of psychiatry·2015
Same author

Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study.

Psychiatric services (Washington, D.C.)·2013

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Combination antipsychotic treatments are common for schizophrenia despite limited safety and efficacy data.
  • Weak literature support and lack of expert guidelines necessitate careful patient monitoring.

Purpose of the Study:

  • To review the evidence for combination antipsychotic treatments in schizophrenia.
  • To identify target symptoms and assess the efficacy of combination therapies.

Main Methods:

  • Literature review of studies on combination treatments for schizophrenia.
  • Analysis of evidence for psychosis, cognitive deficits, and negative symptoms.

Main Results:

  • Strongest evidence supports clozapine augmentation with another antipsychotic or electroconvulsive therapy for persistent positive symptoms.
  • Combination treatments for cognitive deficits and negative symptoms are under investigation but lack sufficient evidence.
  • Adequate trials of monotherapy are recommended before considering combination treatments.

Conclusions:

  • Providers must diligently document outcomes for patients on combination therapies.
  • Current evidence is insufficient to broadly recommend combination treatments for cognitive and negative symptoms.
  • Prioritize adequate monotherapy trials before initiating combination antipsychotic strategies.

Related Experiment Videos